Enterprise Value
1.443M
Cash
1.114M
Avg Qtr Burn
-5.051M
Short % of Float
3.33%
Insider Ownership
12.30%
Institutional Own.
3.87%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CTx-1301 Details Attention deficit hyperactivity disorder, Mental health | Phase 3 Update | |
CTx-1302 Details Mental health, Attention deficit hyperactivity disorder | Phase 1/2 Initiation | |
CTx-2103 (buspirone) Details Mental health, Anxiety Disorders | IND Submission |